B

BARD1 Life Sciences Ltd (ASX: BD1)

21 employees

Developing diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases.

Basic info

Industry

biotechnology research

Sectors

Diagnostics
Life Sciences
Extracellular Vesicles
Cancer Biomarkers
Exosomes
Development
Cancer Diagnostics

Date founded

2016

FAQ